244
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Improving Physical, Physiological, and Psychological Health Outcomes in Patients with Diabetic Foot Ulcers – State of the Art

ORCID Icon & ORCID Icon
Pages 3547-3560 | Received 30 Apr 2023, Accepted 30 Nov 2023, Published online: 12 Dec 2023

References

  • Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021;17:88–93. doi:10.1016/j.jcot.2021.01.017
  • Armstrong DG, Boulton AJM, Bus SA, Ingelfinger JR. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
  • Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):16. doi:10.1186/s13047-020-00383-2
  • Kerr M, Barron E, Chadwick P, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995–1002. doi:10.1111/dme.13973
  • Rice JB, Desai U, Cummings AKG, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37(3):651–658. doi:10.2337/dc13-2176
  • Skrepnek GH, Mills JL, Lavery LA, Armstrong DG. Health care service and outcomes among an estimated 6.7 million ambulatory care diabetic foot cases in the US. Diabetes Care. 2017;40(7):936–942. doi:10.2337/dc16-2189
  • Crawford F, McCowan C, Dimitrov BD, et al. The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM. 2011;104(5):403–410. doi:10.1093/qjmed/hcq227
  • Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377–384.
  • Henriksson F, Agardh CD, Berne C, et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med. 2000;248(5):387–396. doi:10.1046/j.1365-2796.2000.00749.x
  • Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–116. doi:10.1080/07853890.2016.1231932
  • Metcalf L, Musgrove M, Bentley J, et al. Prevalence of active Charcot disease in the East Midlands of England. Diabet Med. 2018;35(10):1371–1374. doi:10.1111/dme.13679
  • O’Loughlin A, Kellegher E, McCusker C, Canavan R. Diabetic charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre. Irish J Med Sci. 2017;186(1):151–156. doi:10.1007/s11845-016-1508-5
  • Salini D, Harish K, Minnie P, et al. Prevalence of charcot arthropathy in type 2 diabetes patients aged over 50 years with severe peripheral neuropathy: a retrospective study in a Tertiary Care South Indian Hospital. Indian J Endocrinol Metab. 2018;22(1):107–111. doi:10.4103/ijem.IJEM_257_17
  • Abbas ZG, Lutale JK, Formosa C, Gatt A, Chockalingam N. The charcot foot: an emerging public health problem for African Diabetes Patients. Int J Low Extrem Wounds. 2021;15347346211066684. doi:10.1177/15347346211066684
  • Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22(7):1036–1042. doi:10.2337/diacare.22.7.1036
  • Vas PR, Edmonds ME. Early recognition of diabetic peripheral neuropathy and the need for one-stop microvascular assessment. Lancet Diabetes Endocrinol. 2016;4(9):723–725. doi:10.1016/S2213-8587(16)30063-8
  • Stevens MJ, Edmonds ME, Foster AV, Watkins PJ. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35(2):148–154. doi:10.1007/BF00402547
  • Khan A, Petropoulos IN, Ponirakis G, et al. Corneal confocal microscopy detects severe small fiber neuropathy in diabetic patients with Charcot neuroarthropathy. J Diabetes Investig. 2018;9(5):1167–1172. doi:10.1111/jdi.12806
  • Dehghani C, Russell AW, Perkins BA, et al. A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot foot. J Diabetes Complication. 2016;30(8):1437–1439. doi:10.1016/j.jdiacomp.2016.07.004
  • Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–350. doi:10.1056/NEJMoa032782
  • Chicharro-Luna E, Pomares-Gómez FJ, Ortega-ávila AB, Marchena-Rodríguez A, Blanquer-Gregori JFJ, Navarro-Flores E. Predictive model to identify the risk of losing protective sensibility of the foot in patients with diabetes mellitus. Int Wound J. 2020;17(1):220–227. doi:10.1111/iwj.13263
  • Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47(5):921–929. doi:10.1016/j.jacc.2005.09.065
  • Formosa C, Cassar K, Gatt A, et al. Hidden dangers revealed by misdiagnosed peripheral arterial disease using ABPI measurement. Diabetes Res Clin Pract. 2013;102(2):112–116. doi:10.1016/j.diabres.2013.10.006
  • Manu CA, Freedman B, Rashid H, Winkley K, Edmonds ME. Peripheral arterial disease located in the feet of patients with diabetes and foot ulceration demands a new approach to the assessment of ischemia. Int J Lower Extremity Wounds. 2020;21(4)1534734620947979.
  • Hinchliffe RJ, Brownrigg JR, Apelqvist J, et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):37–44. doi:10.1002/dmrr.2698
  • Wrobel JS, Najafi B. Diabetic foot biomechanics and gait dysfunction. J Diabetes Sci Technol. 2010;4(4):833–845. doi:10.1177/193229681000400411
  • Formosa C, Gatt A, Chockalingam N. The importance of clinical biomechanical assessment of foot deformity and joint mobility in people living with type-2 diabetes within a primary care setting. Prim Care Diabetes. 2013;7(1):45–50. doi:10.1016/j.pcd.2012.12.003
  • Formosa C, Gatt A, Chockalingam N. Diabetic foot complications in Malta: prevalence of risk factors. Foot. 2012;22(4):294–297. doi:10.1016/j.foot.2012.08.008
  • Ledoux WR, Shofer JB, Smith DG, Sullivan K, Assal M, Reiber GE. Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot. J Rehabilitat Res Dev. 2005;42(5):665–672. doi:10.1682/JRRD.2004.11.0144
  • Segal A, Rohr E, Orendurff M, Shofer J, O’Brien M, Sangeorzan B. The Effect of Walking Speed on Peak Plantar Pressure. Foot Ankle Int. 2004;25(12):926–933. doi:10.1177/107110070402501215
  • Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26(5):1435–1438. doi:10.2337/diacare.26.5.1435
  • Salsich GB, Mueller MJ, Sahrmann SA. Passive ankle stiffness in subjects with diabetes and peripheral neuropathy versus an age-matched comparison group. Phys Ther. 2000;80(4):352–362. doi:10.1093/ptj/80.4.352
  • Williams DB, Brunt D, Tanenberg RJ. Diabetic neuropathy is related to joint stiffness during late stance phase. J Appl Biomech. 2007;23(4):251–260. doi:10.1123/jab.23.4.251
  • Simon-Perez E, Simon-Perez C, Alonso-Pena D, et al. Stiffness degree of ankle range of motion in diabetic patients with atypical amputation. Revista da Associacao Medica Brasileira. 2020;66(2):216–221. doi:10.1590/1806-9282.66.2.216
  • Chatzistergos P, Naemi R, Chockalingam N. The role of tissue biomechanics in improving the clinical management of diabetic foot ulcers. In: The Science, Etiology and Mechanobiology of Diabetes and Its Complications. Elsevier; 2021:123–141.
  • Kwak Y, Kim J, Lee KM, Koo S. Increase of stiffness in plantar fat tissue in diabetic patients. J Biomech. 2020;107:109857. doi:10.1016/j.jbiomech.2020.109857
  • Lazzarini PA, Jarl G, Gooday C, et al. Effectiveness of offloading interventions to heal foot ulcers in persons with diabetes: a systematic review. Diabetes Metab Res Rev. 2020;36(Suppl 1):e3275. doi:10.1002/dmrr.3275
  • Healy A, Naemi R, Chockalingam N. The effectiveness of footwear and other removable off-loading devices in the treatment of diabetic foot ulcers: a systematic review. Curr Diabetes Rev. 2014;10(4):215–230. doi:10.2174/1573399810666140918121438
  • Chatzistergos PE, Naemi R, Chockalingam N. A method for subject-specific modelling and optimisation of the cushioning properties of insole materials used in diabetic footwear. Med Eng Phys. 2015;37(6):531–538. doi:10.1016/j.medengphy.2015.03.009
  • Chatzistergos PE, Naemi R, Sundar L, Ramachandran A, Chockalingam N. The relationship between the mechanical properties of heel-pad and common clinical measures associated with foot ulcers in patients with diabetes. J Diabetes Complication. 2014;28(4):488–493. doi:10.1016/j.jdiacomp.2014.03.011
  • Naemi R, Chatzistergos P, Suresh S, Sundar L, Chockalingam N, Ramachandran A. Can plantar soft tissue mechanics enhance prognosis of diabetic foot ulcer? Diabetes Res Clin Pract. 2017;126:182–191. doi:10.1016/j.diabres.2017.02.002
  • Ndip A, Rutter MK, Vileikyte L, et al. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care. 2010;33(8):1811–1816. doi:10.2337/dc10-0255
  • Lavery LA, Lavery DC, Hunt NA, La Fontaine J, Ndip A, Boulton AJ. Amputations and foot-related hospitalisations disproportionately affect dialysis patients. Int Wound J. 2015;12(5):523–526. doi:10.1111/iwj.12146
  • Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009;9(6):432–434. doi:10.1007/s11892-009-0070-1
  • Meloni M, Izzo V, Giurato L, Cervelli V, Gandini R, Uccioli L. Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers. Journal of Clinical and Translational Endocrinology. 2018;11:31–35. doi:10.1016/j.jcte.2018.01.002
  • Dietrich I, Braga GA, de Melo FG, da Costa Silva Silva ACC. The diabetic foot as a proxy for cardiovascular events and mortality review. Curr Atherosclerosis Rep. 2017;19(11):1–5. doi:10.1007/s11883-017-0680-z
  • Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabet Complication. 1990;4(1):21–25. doi:10.1016/0891-6632(90)90060-I
  • Pan A, Lucas M, Sun Q, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010;170(21):1884–1891. doi:10.1001/archinternmed.2010.356
  • Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383–2390. doi:10.2337/dc08-0985
  • Demakakos P, Pierce MB, Hardy R. Depressive symptoms and risk of type 2 diabetes in a national sample of middle-aged and older adults: the English longitudinal study of aging. Diabetes Care. 2010;33(4):792–797. doi:10.2337/dc09-1663
  • Darwish L, Beroncal E, Sison MV, Swardfager W. Depression in people with type 2 diabetes: current perspectives. Diabetes Metab Syndr Obes. 2018;11:333–343. doi:10.2147/DMSO.S106797
  • Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care. 2007;30(6):1473–1479. doi:10.2337/dc06-2313
  • Vileikyte L, Leventhal H, Gonzalez JS, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005;28(10):2378–2383. doi:10.2337/diacare.28.10.2378
  • Williams LH, Rutter CM, Katon WJ, et al. Depression and incident diabetic foot ulcers: a prospective cohort study. Am J Med. 2010;123(8):748–54 e3. doi:10.1016/j.amjmed.2010.01.023
  • Winkley K, Sallis H, Kariyawasam D, et al. Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality. Diabetologia. 2012;55(2):303–310. doi:10.1007/s00125-011-2359-2
  • Jiang F-H, Liu X-M, H-R Y, Qian Y, Chen H-L. The incidence of depression in patients with diabetic foot ulcers: a systematic review and meta-analysis. Int J Lower Extremity Wounds. 2022;21(2):161–173. doi:10.1177/1534734620929892
  • Gonzalez JS, Vileikyte L, Ulbrecht JS, et al. Depression predicts first but not recurrent diabetic foot ulcers. Diabetologia. 2010;53(10):2241–2248. doi:10.1007/s00125-010-1821-x
  • Moran C, Beare R, Phan T, et al. Neuroimaging and its relevance to understanding pathways linking diabetes and cognitive dysfunction. J Alzheimers Dis. 2017;59(2):405–419. doi:10.3233/JAD-161166
  • Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–545. doi:10.1016/S2213-8587(20)30118-2
  • Moran C, Than S, Callisaya M, Beare R, Srikanth V. New horizons-cognitive dysfunction associated with type 2 diabetes. J Clin Endocrinol Metab. 2022;107(4):929–942. doi:10.1210/clinem/dgab797
  • Rawlings AM, Sharrett AR, Albert MS, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC Study. Diabetes Care. 2019;42(7):1248–1254. doi:10.2337/dc19-0120
  • Natovich R, Kushnir T, Harman-Boehm I, et al. Cognitive dysfunction: part and parcel of the diabetic foot. Diabetes Care. 2016;39(7):1202–1207. doi:10.2337/dc15-2838
  • Amiel SA. The consequences of hypoglycaemia. Diabetologia. 2021;64(5):963–970. doi:10.1007/s00125-020-05366-3
  • Bus SA, Lavery LA, Monteiro‐Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metabol Res Rev. 2020;36(S1):e3269. doi:10.1002/dmrr.3269
  • Singh AK, Gillies CL, Singh R, et al. Prevalence of comorbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab. 2020;22(10):1915–1924. doi:10.1111/dom.14124
  • Patel J, Zamzam A, Syed M, et al. A scoping review of foot screening in adults with diabetes mellitus across Canada. Can J Diabetes. 2022;46(5):435–440.e2. doi:10.1016/j.jcjd.2022.01.004
  • Chevreul K, Berg Brigham K, Bouche C. The burden and treatment of diabetes in France. Global Health. 2014;10(1):6. doi:10.1186/1744-8603-10-6
  • Alonso-Fernandez M, Mediavilla-Bravo JJ, Lopez-Simarro F, et al. Evaluation of diabetic foot screening in Primary Care. Endocrinol Nutr. 2014;61(6):311–317. doi:10.1016/j.endonu.2014.01.007
  • Alkhouli M, Alqahtani F, Elsisy MF, Kawsara A, Alasnag M. Incidence and outcomes of acute ischemic stroke following percutaneous coronary interventions in men versus women. Am J Cardiol. 2020;125(3):336–340. doi:10.1016/j.amjcard.2019.10.045
  • Lawrenson JG, Bourmpaki E, Bunce C, et al. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort. Diabet Med. 2021;38(4):e14425. doi:10.1111/dme.14425
  • Walton DV, Edmonds ME, Bates M, Vas PRJ, Petrova NL, Manu CA. People living with diabetes are unaware of their foot risk status or why they are referred to a multidisciplinary foot team. J Wound Care. 2021;30(8):598–603. doi:10.12968/jowc.2021.30.8.598
  • Schaper NC, van Netten JJ, Apelqvist J, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3266. doi:10.1002/dmrr.3266
  • Manu C, Lacopi E, Bouillet B, et al. Delayed referral of patients with diabetic foot ulcers across Europe: patterns between primary care and specialised units. J Wound Care. 2018;27(3):186–192. doi:10.12968/jowc.2018.27.3.186
  • Musuuza J, Sutherland BL, Kurter S, Balasubramanian P, Bartels CM, Brennan MB. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg. 2020;71(4):1433–46. e3. doi:10.1016/j.jvs.2019.08.244
  • Vas PRJ, Edmonds M, Kavarthapu V, et al. The diabetic foot attack: “Tis Too Late to Retreat!”. Int J Low Extrem Wounds. 2018;17(1):7–13. doi:10.1177/1534734618755582
  • Vainieri E, Ahluwalia R, Slim H, et al. Outcomes after emergency admission with a diabetic foot attack indicate a high rate of healing and limb salvage but increased mortality: 18-month follow-up study. Exp Clin Endocrinol Diabetes. 2022;130(3):165–171. doi:10.1055/a-1322-4811
  • Meloni M, Izzo V, Manu C, et al. Fast-track pathway: an easy-to-use tool to reduce delayed referral and amputations in diabetic patients with foot ulceration. Diabetic Foot. 2019;22(2):39.
  • Bus SA, van Netten JJ, Lavery LA, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):16–24. doi:10.1002/dmrr.2696
  • Frykberg RG, Attinger C, Smeets L, Koller A, Bal A, Kavarthapu V. Surgical strategies for prevention of amputation of the diabetic foot. J Clin Orthop Trauma. 2021;17:99–105. doi:10.1016/j.jcot.2021.02.019
  • Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3276. doi:10.1002/dmrr.3276
  • Bonaca MP, Bauersachs RM, Anand SS, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020;382(21):1994–2004. doi:10.1056/NEJMoa2000052
  • Healy A, Dunning DN, Chockalingam N. Effect of insole material on lower limb kinematics and plantar pressures during treadmill walking. Prosthet Orthot Int. 2012;36(1):53–62. doi:10.1177/0309364611429986
  • Healy A, Farmer S, Pandyan A, Chockalingam N. A systematic review of randomised controlled trials assessing effectiveness of prosthetic and orthotic interventions. PLoS One. 2018;13(3):e0192094. doi:10.1371/journal.pone.0192094
  • Burns J, Wegener C, Begg L, Vicaretti M, Fletcher J. Randomized trial of custom orthoses and footwear on foot pain and plantar pressure in diabetic peripheral arterial disease. Diabet Med. 2009;26(9):893–899. doi:10.1111/j.1464-5491.2009.02799.x
  • Rizzo L, Tedeschi A, Fallani E, et al. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients. Int J Lower Extremity Wounds. 2012;11(1):59–64. doi:10.1177/1534734612438729
  • Zwaferink JBJ, Custers W, Paardekooper I, Berendsen HA, Bus SA, Jan Y-K. Optimizing footwear for the diabetic foot: data-driven custom-made footwear concepts and their effect on pressure relief to prevent diabetic foot ulceration. PLoS One. 2020;15(4):e0224010. doi:10.1371/journal.pone.0224010
  • Waaijman R, Keukenkamp R, de Haart M, Polomski WP, Nollet F, Bus SA. Adherence to wearing prescription custom-made footwear in patients with diabetes at high risk for plantar foot ulceration. Diabetes Care. 2013;36(6):1613–1618. doi:10.2337/dc12-1330
  • Jarl G, Tranberg R, Johansson U, Alnemo J, Lundqvist LO. Predictors of adherence to wearing therapeutic footwear among people with diabetes. J Foot Ankle Res. 2020;13(1):45. doi:10.1186/s13047-020-00413-z
  • Formosa C, Gatt A, Chockalingam N. A Critical Evaluation of Existing Diabetic Foot Screening Guidelines. Rev Diabet Stud. 2016;13(2–3):158–186. doi:10.1900/RDS.2016.13.158
  • van Netten JJ, Price PE, Lavery LA, et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32(Suppl 1):84–98. doi:10.1002/dmrr.2701
  • Hernandez-Contreras D, Peregrina-Barreto H, Rangel-Magdaleno J, Gonzalez-Bernal J. Narrative review: diabetic foot and infrared thermography. Infrared Phys Technol. 2016;78:105–117. doi:10.1016/j.infrared.2016.07.013
  • Petrova NL, Donaldson NK, Tang W, et al. Infrared thermography and ulcer prevention in the high-risk diabetic foot: data from a single-blind multicentre controlled clinical trial. Diabet Med. 2020;37(1):95–104. doi:10.1111/dme.14152
  • Frykberg RG, Gordon IL, Reyzelman AM, et al. Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers. Diabetes Care. 2017;40(7):973–980. doi:10.2337/dc16-2294
  • Abbott CA, Chatwin KE, Foden P, et al. Innovative intelligent insole system reduces diabetic foot ulcer recurrence at plantar sites: a prospective, randomised, proof-of-concept study. Lancet Digit Health. 2019;1(6):e308–e318. doi:10.1016/S2589-7500(19)30128-1
  • Bus SA, Sacco ICN, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev;2023. e3651. doi:10.1002/dmrr.3651
  • Kurkela O, Lahtela J, Arffman M, Forma L. Infrared thermography compared to standard care in the prevention and care of diabetic foot: a cost analysis utilizing real-world data and an expert panel. Clinicoecon Outcomes Res. 2023;15:111–123. doi:10.2147/CEOR.S396137
  • El-Nahas M, El-Shazly S, El-Gamel F, Motawea M, Kyrillos F, Idrees H. Relationship between skin temperature monitoring with Smart Socks and plantar pressure distribution: a pilot study. J Wound Care. 2018;27(8):536–541. doi:10.12968/jowc.2018.27.8.536
  • Najafi B, Mohseni H, Grewal GS, Talal TK, Menzies RA, Armstrong DG. An Optical-Fiber-Based Smart Textile (Smart Socks) to manage biomechanical risk factors associated with diabetic foot amputation. J Diabetes Sci Technol. 2017;11(4):668–677. doi:10.1177/1932296817709022
  • Armstrong DG. Subscription prescription: remote patient monitoring using smart shoes, socks and insoles. J Wound Care. 2019;28(Sup9):S3. doi:10.12968/jowc.2019.28.Sup9.S3
  • Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065–2079. doi:10.2337/dc16-1728
  • Dasanayake IS, Bevier WC, Castorino K, et al. Early detection of physical activity for people with type 1 diabetes mellitus. J Diabetes Sci Technol. 2015;9(6):1236–1245. doi:10.1177/1932296815592409
  • Armstrong DG, Lavery LA, Holtz-Neiderer K, et al. Variability in activity may precede diabetic foot ulceration. Diabetes Care. 2004;27(8):1980–1984. doi:10.2337/diacare.27.8.1980
  • Bus SA, Aan de Stegge WB, van Baal JG, Busch-Westbroek TE, Nollet F, van Netten JJ. Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP). BMJ Open Diabetes Res Care. 2021;9(1):e002392. doi:10.1136/bmjdrc-2021-002392
  • Filipe V, Teixeira P, Teixeira A. Automatic classification of foot thermograms using machine learning techniques. Algorithms. 2022;15(7):236. doi:10.3390/a15070236
  • Chatzistergos PE, Chockalingam N. A novel concept for low-cost non-electronic detection of overloading in the foot during activities of daily living. Royal Soc Open Sci. 2021;8(6):202035. doi:10.1098/rsos.202035
  • Perren S, Formosa C, Camilleri L, Chockalingam N, Gatt A. The thermo-pressure concept: a new model in diabetic foot risk stratification. Appl Sci. 2021;11(16):7473. doi:10.3390/app11167473
  • Walk With Path. Path Feel. An innovative solution for sensory deficit. Available from: https://www.walkwithpath.com/pages/path-feel-for-professionals. Accessed October 20, 2023.
  • Ipp E, Liljenquist D, Bode B, et al. Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy. JAMA network open. 2021;4(11):e2134254. doi:10.1001/jamanetworkopen.2021.34254
  • Ellahham S. Artificial Intelligence: the future for diabetes care. Am J Med. 2020;133(8):895–900. doi:10.1016/j.amjmed.2020.03.033
  • Shao H, Shi L, Lin Y, Fonseca V. Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: a focus on the BRAVO model. J diabet complicat. 2022;36(11):108316. doi:10.1016/j.jdiacomp.2022.108316
  • Tchero H, Noubou L, Becsangele B, Mukisi-Mukaza M, Retali G-R, Rusch E. Telemedicine in diabetic foot care: a systematic literature review of interventions and meta-analysis of controlled trials. Int J Lower Extremity Wounds. 2017;16(4):274–283. doi:10.1177/1534734617739195
  • Yammine K, Estephan M. Telemedicine and diabetic foot ulcer outcomes. A meta-analysis of controlled trials. Foot. 2022;50:101872. doi:10.1016/j.foot.2021.101872
  • Pedras S, Carvalho R, Pereira MG. Predictors of quality of life in patients with diabetic foot ulcer: the role of anxiety, depression, and functionality. J Health Psychol. 2018;23(11):1488–1498. doi:10.1177/1359105316656769
  • Dorresteijn JAN, Kriegsman DMW, Assendelft WJJ, Valk GD. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev. 2012. doi:10.1002/14651858.CD001488.pub4